中医治疗骨质疏松性腰椎压缩性骨折的研究进展
Research Progress on Traditional Chinese Medicine in the Treatment of Osteoporotic Lumbar Vertebral Compression Fractures
DOI: 10.12677/acm.2026.1672712, PDF,   
作者: 黄丹树, 尹泓静:黑龙江中医药大学研究生院,黑龙江 哈尔滨;王树人*:黑龙江中医药大学附属第一医院骨伤传统治疗部,黑龙江 哈尔滨
关键词: 骨质疏松性椎体压缩骨折三期辨证微观机制术后残余痛中西医结合综述Osteoporotic Vertebral Compression Fractures (OVCF) Three-Staged Syndrome Differentiation Micro-Mechanisms Postoperative Residual Pain Integrated Chinese and Western Medicine Review
摘要: 骨质疏松性腰椎压缩性骨折(OVCF)作为老年人群高发的致残性疾病,给社会及家庭带来沉重的医疗负担。随着现代医学对局部解剖复位与全身骨稳态认识的深化,单纯外科微创干预在改善远期微环境及防治残余痛方面的局限性日益显现。中医学基于“骨断筋伤”与“脏腑气血失调”的理论渊源,发挥整体观念与辨证论治优势,在弥补西医治疗短板中展现出独特价值。本文系统梳理OVCF的中医病因病机、分期内治、外治协同及微观网络研究进展,以期为中西医结合临床路径的优化提供高等级循证依据,并对现有研究的方法学局限进行客观评价,展望了中西医协同及数字化骨科与中医药结合的未来发展趋势。
Abstract: Osteoporotic vertebral compression fractures (OVCF), as a highly prevalent and debilitating disease among the elderly population, impose a heavy medical burden on both society and families. With the deepening understanding of local anatomical reduction and systemic bone homeostasis in modern medicine, the limitations of sole surgical minimally invasive interventions in improving the long-term microenvironment and preventing residual pain have become increasingly prominent. Based on the theoretical origins of “fractured bones and damaged tendons” and “dysregulation of visceral Qi and blood”, Traditional Chinese Medicine (TCM) leverages its advantages of holistic conception and syndrome differentiation, demonstrating unique value in addressing the shortfalls of Western medical treatments. This article systematically reviews the research progress on the etiology, pathogenesis, staged internal treatment, synergistic external treatment, and molecular micro-network mechanisms of TCM for OVCF. It aims to provide high-level evidence-based support for optimizing clinical pathways integrating Chinese and Western medicine, objectively evaluate the methodological limitations of current studies, and prospect the future trends of Chinese-Western medical synergy as well as the integration of digital orthopedics with TCM.
文章引用:黄丹树, 尹泓静, 王树人. 中医治疗骨质疏松性腰椎压缩性骨折的研究进展[J]. 临床医学进展, 2026, 16(7): 1872-1879. https://doi.org/10.12677/acm.2026.1672712

参考文献

[1] 工作组中国老年骨质疏松症诊疗指南, 等. 中国老年骨质疏松症诊疗指南(2023) [J]. 中华骨与关节外科杂志, 2023. 16(10): 865-885.
[2] 邱潇锋, 刘琼, 杜思能, 等. 中医治疗老年骨质疏松椎体压缩性骨折研究进展[J]. 实用中医药杂志, 2022, 38(12): 2256-2258.
[3] 杜龙宇, 薛航, 曹发奇, 等. 老年骨质疏松性胸腰椎压缩性骨折的诊疗进展[J]. 临床外科杂志, 2024, 32(4): 438-441.
[4] 丁悦, 张嘉, 岳华, 等. 骨质疏松性椎体压缩性骨折诊疗与管理专家共识[J]. 中华骨质疏松和骨矿盐疾病杂志, 2018, 11(5): 425-437.
[5] 刘忠培, 陈皓. 骨痿汤联合针刺治疗老年骨质疏松性胸腰椎压缩骨折临床观察[J]. 中国中医药现代远程教育, 2025, 23(21): 156-159.
[6] 陈小军. 中和医派补肾壮骨汤治疗老年骨质疏松性胸腰椎压缩性骨折临床观察[J]. 光明中医, 2025, 40(19): 4230-4233.
[7] 中华中医药学会. 骨质疏松性骨折中医诊疗指南[J]. 中医正骨, 2023, 35(1): 1-9.
[8] 马拥军, 陈彦军, 卢健, 等. 桃红四物汤加味治疗骨质疏松性胸腰椎压缩性骨折的临床研究[J]. 陕西中医, 2018, 39(3): 374-376.
[9] 张振东. 化瘀接骨汤联合碳酸钙D3对骨质疏松性胸腰椎骨折患者术后骨密度和骨代谢的影响[J]. 医药论坛杂志, 2025, 46(20): 2232-2236.
[10] 薛师. 益肾健骨汤联合PVP治疗骨质疏松性胸腰椎压缩性骨折的疗效观察[J]. 实用中西医结合临床, 2025, 25(11): 32-35.
[11] 潘宏赵, 郑陈平, 邓庆卓, 等. 鲑降钙素联合益肾补髓汤治疗在老年骨质疏松性胸腰椎骨折经皮椎体成形术后的应用效果分析[J]. 岭南急诊医学杂志, 2020, 25(6): 600-602.
[12] 潘磊, 倪力刚, 胡劲涛, 等. 督脉隔药饼灸治疗肾虚血瘀型骨质疏松性腰椎压缩性骨折经皮球囊扩张椎体后凸成形术术后残余痛临床研究[J]. 新中医, 2021, 53(6): 105-108.
[13] 崔立军, 陈常柏, 李仕成. 火龙灸配合自拟补肾活血汤治疗老年骨质疏松性椎体压缩性骨折的效果观察[J]. 中国现代药物应用, 2022, 16(5): 190-193.
[14] 王芸, 李伶俐, 胡锦庆, 等. 元气针灸治疗肾虚型骨质疏松症临床疗效观察[J]. 中华中医药学刊, 2025, 43(5): 247-250.
[15] 杜育海, 周茜, 蒋慧娟, 等. 骨松宝颗粒配合氟比洛芬凝胶治疗老年胸腰椎压缩性骨折患者术后早期残余疼痛的临床效果[J]. 中国老年学杂志, 2024, 44(17): 4135-4138.
[16] 关丽瑶, 任霞. 中药外敷联合内服对骨质疏松性椎体压缩性骨折患者术后康复的影响[J]. 河南医学研究, 2021, 30(12): 2263-2265.
[17] 胡伟, 张斌, 陶志强, 等. 仙灵骨葆胶囊对老年骨质疏松性胸腰椎压缩性骨折术后骨密度及炎症因子水平的影响[J]. 河南中医, 2025, 45(8): 1269-1273.
[18] 谢兴文, 王小强, 徐世红, 等. 中药苷类化合物防治骨质疏松症作用机制的研究进展[J]. 中华中医药学刊, 2023, 41(11): 5-9.